We are pleased to announce that Bushu Pharma has received the 2023 Japan Contract Development and Manufacturing Customer Value Leadership Award from Frost & Sullivan, a leading global research and consulting firm.

In addition to our optimization efforts in our supply chain services with the GATEWAY to ASIA® strategy, which was highly recognized last year, we were mainly evaluated for our customer-centric approach, such as enhancing our partnerships with the rapidly growing biotechnology companies.

Read the full article here: https://www.prnewswire.com/news-releases/bushu-pharma-recognized-with-frost–sullivans-2023-japan-customer-value-leadership-award-for-offering-advanced-pharmaceutical-manufacturing-and-robust-supply-chain-solutions-302000254.html

We will continue to contribute to the medical field by providing new technologies and solutions based on our mission of “Supporting the global healthcare industry to create a healthier tomorrow”.